Search Results

SC514 50mg  | ≥99%

CSNpharm

SC514 is a potent, reversible, ATP-competitive and highly selective IKK-β(IKK-2) inhibitor with IC50 value ranging in 3-12 µM.

More Information Supplier Page

SC514 5mg  | ≥99%

CSNpharm

SC514 is a potent, reversible, ATP-competitive and highly selective IKK-β(IKK-2) inhibitor with IC50 value ranging in 3-12 µM.

More Information Supplier Page

Orlistat 250mg  | ≥98%

CSNpharm

Orlistat is an approved reversible general lipase inhibitor with IC50 of 122 ng/mL, used to treat obesity.

More Information Supplier Page

Orlistat 100mg  | ≥98%

CSNpharm

Orlistat is an approved reversible general lipase inhibitor with IC50 of 122 ng/mL, used to treat obesity.

More Information Supplier Page

Orlistat 50mg  | ≥98%

CSNpharm

Orlistat is an approved reversible general lipase inhibitor with IC50 of 122 ng/mL, used to treat obesity.

More Information Supplier Page

Orlistat 10mg  | ≥98%

CSNpharm

Orlistat is an approved reversible general lipase inhibitor with IC50 of 122 ng/mL, used to treat obesity.

More Information Supplier Page

Finasteride 250mg  | ≥99%

CSNpharm

Finasteride is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).

More Information Supplier Page

Finasteride 100mg  | ≥99%

CSNpharm

Finasteride is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).

More Information Supplier Page

Finasteride 25mg  | ≥99%

CSNpharm

Finasteride is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).

More Information Supplier Page